Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peptidylprolyl Isomerase | 24 | 2020 | 105 | 3.280 |
Why?
|
Breast Neoplasms | 36 | 2024 | 20822 | 1.210 |
Why?
|
BRCA1 Protein | 10 | 2022 | 1149 | 0.920 |
Why?
|
Infectious Mononucleosis | 2 | 2022 | 131 | 0.910 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2016 | 2942 | 0.890 |
Why?
|
Phthalazines | 7 | 2022 | 363 | 0.830 |
Why?
|
Mammary Neoplasms, Experimental | 5 | 2021 | 520 | 0.710 |
Why?
|
Ovarian Neoplasms | 6 | 2022 | 4838 | 0.680 |
Why?
|
Phosphatidylinositol 3-Kinases | 8 | 2024 | 2938 | 0.670 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2020 | 450 | 0.670 |
Why?
|
Genes, BRCA1 | 3 | 2023 | 781 | 0.660 |
Why?
|
Fructose-Bisphosphate Aldolase | 2 | 2020 | 52 | 0.600 |
Why?
|
Gene Fusion | 2 | 2019 | 371 | 0.600 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2022 | 11524 | 0.550 |
Why?
|
Ubiquitin | 2 | 2020 | 852 | 0.550 |
Why?
|
Nucleosides | 1 | 2016 | 138 | 0.540 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 570 | 0.540 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1041 | 0.520 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5172 | 0.500 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2017 | 2948 | 0.490 |
Why?
|
Mammary Glands, Animal | 4 | 2017 | 276 | 0.470 |
Why?
|
Breast | 6 | 2020 | 1969 | 0.470 |
Why?
|
DNA Damage | 5 | 2020 | 2432 | 0.460 |
Why?
|
Receptor, erbB-2 | 9 | 2021 | 2416 | 0.460 |
Why?
|
BRCA2 Protein | 4 | 2022 | 794 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2019 | 2503 | 0.390 |
Why?
|
Morpholines | 3 | 2019 | 571 | 0.370 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 16689 | 0.360 |
Why?
|
Interleukin-8 | 1 | 2013 | 690 | 0.360 |
Why?
|
Furans | 2 | 2021 | 194 | 0.360 |
Why?
|
Ketones | 2 | 2021 | 188 | 0.360 |
Why?
|
Aminopyridines | 3 | 2019 | 542 | 0.350 |
Why?
|
Piperazines | 5 | 2022 | 2488 | 0.350 |
Why?
|
Epithelial Cells | 5 | 2016 | 3690 | 0.330 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4186 | 0.310 |
Why?
|
Mutation | 13 | 2024 | 29786 | 0.310 |
Why?
|
Signal Transduction | 19 | 2021 | 23403 | 0.300 |
Why?
|
Cyclin D1 | 4 | 2004 | 463 | 0.280 |
Why?
|
Neoplasms | 6 | 2021 | 21683 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5535 | 0.240 |
Why?
|
Mice, SCID | 4 | 2021 | 2716 | 0.240 |
Why?
|
Pyruvic Acid | 2 | 2022 | 200 | 0.230 |
Why?
|
Pentose Phosphate Pathway | 2 | 2021 | 124 | 0.230 |
Why?
|
Mice | 29 | 2021 | 81183 | 0.220 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2187 | 0.220 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 437 | 0.210 |
Why?
|
Female | 54 | 2024 | 380194 | 0.210 |
Why?
|
Cell Division | 2 | 2009 | 4568 | 0.200 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1878 | 0.200 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.200 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 425 | 0.200 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1861 | 0.200 |
Why?
|
Animals | 37 | 2022 | 168757 | 0.200 |
Why?
|
Humans | 80 | 2024 | 744343 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2020 | 8428 | 0.190 |
Why?
|
Nipples | 1 | 2023 | 219 | 0.190 |
Why?
|
Testosterone | 3 | 2023 | 2420 | 0.190 |
Why?
|
Cell Differentiation | 7 | 2021 | 11483 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2001 | 286 | 0.190 |
Why?
|
Gene Deletion | 3 | 2021 | 2751 | 0.190 |
Why?
|
Ear | 1 | 2001 | 173 | 0.180 |
Why?
|
Vincristine | 5 | 2020 | 1039 | 0.180 |
Why?
|
Niacinamide | 1 | 2022 | 417 | 0.180 |
Why?
|
Mitosis | 5 | 2020 | 1208 | 0.180 |
Why?
|
Cyclins | 1 | 2002 | 603 | 0.180 |
Why?
|
Retinal Dehydrogenase | 2 | 2011 | 74 | 0.180 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2023 | 486 | 0.180 |
Why?
|
Transcriptional Activation | 4 | 2015 | 1783 | 0.180 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 890 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2022 | 2077 | 0.170 |
Why?
|
Phosphorylation | 13 | 2020 | 8436 | 0.170 |
Why?
|
Mice, Knockout | 11 | 2021 | 14557 | 0.170 |
Why?
|
Cell Cycle | 4 | 2020 | 2967 | 0.170 |
Why?
|
Cells, Cultured | 9 | 2020 | 19229 | 0.170 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2020 | 237 | 0.170 |
Why?
|
NAD | 1 | 2022 | 593 | 0.160 |
Why?
|
Prothrombin | 1 | 1999 | 185 | 0.160 |
Why?
|
Immunohistochemistry | 7 | 2019 | 11366 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2020 | 987 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4479 | 0.160 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6314 | 0.160 |
Why?
|
Factor V | 1 | 1999 | 178 | 0.160 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2020 | 431 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2021 | 3557 | 0.160 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.160 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2019 | 462 | 0.150 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6895 | 0.150 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2019 | 215 | 0.150 |
Why?
|
Isoenzymes | 3 | 2013 | 1726 | 0.150 |
Why?
|
Breast Diseases | 1 | 2020 | 443 | 0.150 |
Why?
|
Protons | 1 | 2022 | 1127 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 1999 | 513 | 0.140 |
Why?
|
RNA Interference | 3 | 2016 | 2889 | 0.140 |
Why?
|
Mammary Glands, Human | 1 | 2017 | 199 | 0.140 |
Why?
|
Macrophages | 2 | 2022 | 5655 | 0.140 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 118 | 0.140 |
Why?
|
Carboplatin | 1 | 2019 | 801 | 0.140 |
Why?
|
Glycolysis | 2 | 2020 | 827 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 415 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1012 | 0.130 |
Why?
|
Thiazoles | 2 | 2022 | 1483 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1097 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9438 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2016 | 130 | 0.130 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 186 | 0.130 |
Why?
|
Sirolimus | 3 | 2016 | 1564 | 0.130 |
Why?
|
MAP Kinase Signaling System | 3 | 2020 | 1526 | 0.130 |
Why?
|
Centrosome | 2 | 2006 | 201 | 0.130 |
Why?
|
Microtubules | 2 | 2020 | 1090 | 0.130 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1634 | 0.130 |
Why?
|
Catalysis | 3 | 2006 | 761 | 0.130 |
Why?
|
Cytomegalovirus | 1 | 2019 | 732 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2019 | 3023 | 0.120 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2017 | 440 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 934 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3920 | 0.120 |
Why?
|
Neoplasm Metastasis | 7 | 2021 | 4851 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5256 | 0.120 |
Why?
|
Homozygote | 1 | 1999 | 1785 | 0.120 |
Why?
|
Transcription, Genetic | 5 | 2008 | 7722 | 0.120 |
Why?
|
Cell Proliferation | 5 | 2020 | 10481 | 0.120 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 713 | 0.120 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3505 | 0.120 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13695 | 0.120 |
Why?
|
Drug Synergism | 2 | 2021 | 1792 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18029 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1758 | 0.110 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 246 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 21827 | 0.110 |
Why?
|
ras Proteins | 3 | 2004 | 1060 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1607 | 0.110 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 321 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.110 |
Why?
|
Immunoblotting | 1 | 2016 | 1682 | 0.110 |
Why?
|
Cytosol | 1 | 2016 | 901 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1660 | 0.110 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3586 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2021 | 2382 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 484 | 0.100 |
Why?
|
Phenotype | 5 | 2022 | 16365 | 0.100 |
Why?
|
Adult | 22 | 2023 | 214055 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 873 | 0.100 |
Why?
|
Pyruvate Kinase | 1 | 2013 | 189 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2001 | 1052 | 0.100 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2011 | 61 | 0.100 |
Why?
|
Telomeric Repeat Binding Protein 1 | 2 | 2008 | 5 | 0.100 |
Why?
|
Epidermal Growth Factor | 2 | 2011 | 708 | 0.100 |
Why?
|
Virus Replication | 1 | 2019 | 2534 | 0.100 |
Why?
|
Estradiol | 1 | 2018 | 2020 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.100 |
Why?
|
DNA Repair | 1 | 2020 | 2046 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2017 | 2085 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 114 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2016 | 1185 | 0.090 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 74 | 0.090 |
Why?
|
beta Catenin | 3 | 2006 | 1059 | 0.090 |
Why?
|
RNA, Neoplasm | 2 | 2009 | 769 | 0.090 |
Why?
|
Hematopoiesis | 3 | 1994 | 2072 | 0.090 |
Why?
|
Mice, Nude | 3 | 2021 | 3689 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
Middle Aged | 21 | 2023 | 213383 | 0.090 |
Why?
|
Aged | 17 | 2023 | 163280 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1239 | 0.090 |
Why?
|
DNA, Viral | 1 | 2016 | 2225 | 0.090 |
Why?
|
Neoplastic Stem Cells | 2 | 2015 | 1376 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 2 | 2008 | 1990 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2109 | 0.080 |
Why?
|
Telomere | 2 | 2008 | 910 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3703 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2016 | 2715 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4445 | 0.080 |
Why?
|
Drug Resistance | 2 | 1994 | 1609 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12788 | 0.080 |
Why?
|
DNA-Binding Proteins | 5 | 2009 | 9648 | 0.080 |
Why?
|
Genes, p53 | 1 | 2011 | 755 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1678 | 0.080 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2009 | 142 | 0.080 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 1788 | 0.080 |
Why?
|
Amino Acid Motifs | 4 | 2021 | 936 | 0.080 |
Why?
|
Phosphothreonine | 2 | 2005 | 63 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2003 | 1213 | 0.080 |
Why?
|
Alzheimer Disease | 4 | 2006 | 8037 | 0.080 |
Why?
|
Isomerism | 2 | 2005 | 201 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2002 | 3462 | 0.080 |
Why?
|
Asthenozoospermia | 1 | 2007 | 6 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13408 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 3 | 1994 | 3386 | 0.070 |
Why?
|
Protein Stability | 1 | 2008 | 557 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3479 | 0.070 |
Why?
|
Organoids | 2 | 2023 | 701 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2003 | 1364 | 0.070 |
Why?
|
Receptors, Progesterone | 2 | 2021 | 1097 | 0.070 |
Why?
|
Hodgkin Disease | 3 | 1998 | 1415 | 0.070 |
Why?
|
Membrane Proteins | 3 | 2019 | 7880 | 0.070 |
Why?
|
Etoposide | 4 | 2019 | 641 | 0.060 |
Why?
|
Androgen Receptor Antagonists | 1 | 2006 | 114 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5524 | 0.060 |
Why?
|
Phosphoserine | 1 | 2005 | 206 | 0.060 |
Why?
|
Sexual Abstinence | 1 | 2004 | 16 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.060 |
Why?
|
Quinazolines | 1 | 2011 | 1356 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9734 | 0.060 |
Why?
|
Keratin-7 | 1 | 2023 | 57 | 0.060 |
Why?
|
Testis | 1 | 2007 | 803 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 1994 | 3768 | 0.060 |
Why?
|
Down-Regulation | 2 | 2008 | 3002 | 0.060 |
Why?
|
Protein Binding | 7 | 2020 | 9386 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3523 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1994 | 1596 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9274 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 4554 | 0.050 |
Why?
|
Spermatozoa | 1 | 2007 | 625 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2003 | 5021 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1655 | 0.050 |
Why?
|
Trans-Activators | 2 | 2003 | 2924 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 432 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 365 | 0.050 |
Why?
|
6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3798 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 313 | 0.050 |
Why?
|
Apoptosis | 4 | 2021 | 9727 | 0.050 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2021 | 80 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6580 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 261 | 0.050 |
Why?
|
Mastectomy | 2 | 2020 | 1793 | 0.050 |
Why?
|
Doxorubicin | 4 | 2020 | 2234 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 644 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1121 | 0.050 |
Why?
|
Alanine | 1 | 2022 | 572 | 0.050 |
Why?
|
Adolescent | 6 | 2022 | 85781 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2023 | 618 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9239 | 0.040 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2001 | 224 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 56430 | 0.040 |
Why?
|
Granzymes | 1 | 2021 | 271 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
Male | 18 | 2023 | 350118 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 452 | 0.040 |
Why?
|
Blood Coagulation Factor Inhibitors | 1 | 1999 | 16 | 0.040 |
Why?
|
Molecular Sequence Data | 7 | 2013 | 18111 | 0.040 |
Why?
|
Idarubicin | 1 | 2019 | 62 | 0.040 |
Why?
|
Gene Expression | 4 | 2006 | 7799 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2020 | 291 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 666 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 250 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 252 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2021 | 63114 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10943 | 0.040 |
Why?
|
Fibroblasts | 3 | 2023 | 4161 | 0.040 |
Why?
|
Symporters | 1 | 2021 | 362 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 597 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 320 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.040 |
Why?
|
Blood Coagulation Tests | 1 | 1999 | 263 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 130 | 0.040 |
Why?
|
Base Sequence | 5 | 2013 | 12797 | 0.040 |
Why?
|
Nuclear Family | 1 | 1999 | 318 | 0.040 |
Why?
|
Models, Molecular | 3 | 2017 | 5456 | 0.040 |
Why?
|
Nucleotides | 1 | 2020 | 464 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 203 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2021 | 826 | 0.040 |
Why?
|
Azacitidine | 1 | 2019 | 347 | 0.040 |
Why?
|
Protein Conformation | 1 | 2005 | 4011 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4420 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 188 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13102 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 892 | 0.040 |
Why?
|
Thiophenes | 1 | 2021 | 588 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 2 | 1998 | 1770 | 0.040 |
Why?
|
Protein Structure, Tertiary | 4 | 2006 | 3846 | 0.040 |
Why?
|
Pyridones | 1 | 2021 | 712 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.030 |
Why?
|
Chromosomal Instability | 2 | 2008 | 184 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 893 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1285 | 0.030 |
Why?
|
Antithrombins | 1 | 1999 | 304 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2020 | 624 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2025 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
Transfection | 4 | 2006 | 5892 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1999 | 532 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1284 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2021 | 1159 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 695 | 0.030 |
Why?
|
Homocysteine | 1 | 1999 | 647 | 0.030 |
Why?
|
RNA, Messenger | 4 | 1994 | 13033 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1265 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2001 | 806 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 2513 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 35421 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2029 | 0.030 |
Why?
|
NF-kappa B | 1 | 2003 | 2499 | 0.030 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.030 |
Why?
|
Procarbazine | 3 | 1998 | 181 | 0.030 |
Why?
|
Phenanthrolines | 1 | 2014 | 55 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 344 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 338 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1566 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2480 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
Cell Line | 5 | 2011 | 15997 | 0.030 |
Why?
|
Equipment Design | 1 | 2022 | 3582 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 4 | 2007 | 3772 | 0.030 |
Why?
|
Child | 1 | 2022 | 77709 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2916 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1993 | 95 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 976 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1662 | 0.030 |
Why?
|
RNA, Antisense | 1 | 1993 | 138 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 242 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2915 | 0.030 |
Why?
|
Bleomycin | 3 | 1998 | 512 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 201 | 0.030 |
Why?
|
CHO Cells | 2 | 2006 | 1406 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2002 | 5867 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2006 | 3587 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2001 | 12072 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 2 | 2011 | 1142 | 0.030 |
Why?
|
Mutagenesis | 2 | 2013 | 1266 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1679 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1538 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 77449 | 0.030 |
Why?
|
Heterozygote | 1 | 1999 | 2804 | 0.030 |
Why?
|
Cricetinae | 2 | 2006 | 2472 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2006 | 11124 | 0.030 |
Why?
|
Cell Membrane | 1 | 2021 | 3748 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3479 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1157 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
Metabolome | 1 | 2017 | 895 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4217 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 809 | 0.020 |
Why?
|
Warfarin | 1 | 1999 | 1496 | 0.020 |
Why?
|
Cytokines | 2 | 2021 | 7322 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2505 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8664 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2006 | 1547 | 0.020 |
Why?
|
tau Proteins | 1 | 1999 | 1868 | 0.020 |
Why?
|
Prednisone | 3 | 1998 | 1574 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 32 | 0.020 |
Why?
|
DNA Primers | 1 | 1993 | 2892 | 0.020 |
Why?
|
Verapamil | 1 | 1989 | 244 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1889 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2728 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12208 | 0.020 |
Why?
|
RNA Splicing | 1 | 2013 | 907 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11031 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1993 | 970 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 1998 | 2242 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2459 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1799 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1701 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5853 | 0.020 |
Why?
|
Exons | 1 | 2013 | 2437 | 0.020 |
Why?
|
Acrosome Reaction | 1 | 2007 | 8 | 0.020 |
Why?
|
Sperm Head | 1 | 2007 | 10 | 0.020 |
Why?
|
Litter Size | 1 | 2007 | 54 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2849 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.020 |
Why?
|
Vinblastine | 2 | 1998 | 502 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2001 | 13815 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3616 | 0.020 |
Why?
|
Rats | 1 | 2022 | 24260 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 72290 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2007 | 262 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2006 | 140 | 0.020 |
Why?
|
Interphase | 1 | 2006 | 226 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2006 | 154 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
Threonine | 1 | 2006 | 279 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3521 | 0.020 |
Why?
|
Dacarbazine | 2 | 1998 | 566 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6386 | 0.020 |
Why?
|
HeLa Cells | 2 | 2001 | 3128 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2011 | 1275 | 0.020 |
Why?
|
Cricetulus | 1 | 2006 | 816 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 677 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 733 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6364 | 0.010 |
Why?
|
Telomerase | 1 | 2008 | 730 | 0.010 |
Why?
|
Cell Communication | 1 | 2011 | 1621 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 225 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2003 | 175 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6114 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 252 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 275 | 0.010 |
Why?
|
Aneuploidy | 1 | 2006 | 530 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 277 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 898 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6538 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2001 | 6622 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 959 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 380 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 880 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1058 | 0.010 |
Why?
|
Czech Republic | 1 | 1998 | 69 | 0.010 |
Why?
|
Filgrastim | 1 | 1998 | 133 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7301 | 0.010 |
Why?
|
Caspase 3 | 1 | 2001 | 758 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10180 | 0.010 |
Why?
|
Austria | 1 | 1998 | 203 | 0.010 |
Why?
|
Switzerland | 1 | 1998 | 255 | 0.010 |
Why?
|
Brain | 2 | 2022 | 26385 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.010 |
Why?
|
Leukemia | 2 | 1998 | 1511 | 0.010 |
Why?
|
Caspases | 1 | 2001 | 928 | 0.010 |
Why?
|
Xenopus | 1 | 1999 | 712 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 1999 | 595 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.010 |
Why?
|
Cadherins | 1 | 2001 | 907 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 1791 | 0.010 |
Why?
|
Germany | 1 | 1998 | 862 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1998 | 648 | 0.010 |
Why?
|
Protein Transport | 1 | 2001 | 1988 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1999 | 1801 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3701 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1994 | 76 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1994 | 198 | 0.010 |
Why?
|
Thionucleotides | 1 | 1994 | 107 | 0.010 |
Why?
|
Prostatectomy | 1 | 2003 | 1890 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5217 | 0.010 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1994 | 87 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1994 | 356 | 0.010 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1994 | 193 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6473 | 0.010 |
Why?
|
Guanosine Diphosphate | 1 | 1993 | 85 | 0.010 |
Why?
|
Remission Induction | 1 | 1998 | 2386 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1157 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 246 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 1994 | 657 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2969 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 821 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1989 | 5181 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1061 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1999 | 2440 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 4933 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1993 | 2839 | 0.010 |
Why?
|
Cytarabine | 1 | 1989 | 692 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4320 | 0.000 |
Why?
|
Cattle | 1 | 1993 | 3922 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 8949 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1998 | 8642 | 0.000 |
Why?
|
United States | 1 | 2012 | 69872 | 0.000 |
Why?
|
Antigens, CD | 1 | 1994 | 4026 | 0.000 |
Why?
|
Dexamethasone | 1 | 1989 | 1951 | 0.000 |
Why?
|
Disease Progression | 1 | 1998 | 13284 | 0.000 |
Why?
|
Cohort Studies | 1 | 2003 | 40561 | 0.000 |
Why?
|